LAURA ONORATO: Open Payments
NPI 1093809477 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,014 in 21 payments from 11 companies in 2025. Trend: 2023 $1,542 · 2024 $1,829 · 2025 $2,014
Consulting: $1,080Food & beverage: $659Education: $275
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $1,089 |
| Astellas Pharma US Inc | 6 | $418 |
| Phathom Pharmaceuticals, Inc. | 1 | $119 |
| Lilly USA, LLC | 2 | $111 |
| E.R. Squibb & Sons, L.L.C. | 1 | $75 |
| Janssen Biotech, Inc. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Incyte Corporation | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $20 |
Products named: XTANDI, VOQUEZNA, ZEPBOUND, OPDIVO, LIBTAYO, Monjuvi, RYBREVANT, TECVAYLI.
Industry payments across NM — which companies pay providers there.
